Joel Kaye, PhD
VICE PRESIDENT, RESEARCH AND NONCLINICAL DEVELOPMENT
Joel Kaye, PhD, joins Ayala with extensive experience in pharmacology and drug development. Prior to Ayala, Joel held various leadership positions at the Global R&D, Teva Pharmaceutical (NYSE: TEVA), focusing on nonclinical and pharmacological development of numerous products. In his last role, Joel was a Director at the Pharmacology Department, Discovery & Product Development and was the head of Cancer Pharmacology and new model development. Joel’s experience in drug development extends across the clinical development pathway, from discovery to Phase 3 and post-marketing life cycle management. Joel is an inventor or co-inventor of 13 patents and has published 20 articles. Joel did his Post-Doctoral Fellowship at Massachusetts General Hospital and Harvard Medical School and has a PhD in Immunology from the Weizmann Institute of Science, Israel.